183 related articles for article (PubMed ID: 12931132)
1. Ethical, social and legal issues in pharmacogenomics.
Wertz DC
Pharmacogenomics J; 2003; 3(4):194-6. PubMed ID: 12931132
[No Abstract] [Full Text] [Related]
2. Ethical, social and legal implications of pharmacogenomics: a critical review.
Moldrup C
Community Genet; 2001; 4(4):204-14. PubMed ID: 12751484
[TBL] [Abstract][Full Text] [Related]
3. Pharmacogenetics and ethical considerations: why care?
Marx-Stölting L
Pharmacogenomics J; 2007 Oct; 7(5):293-6. PubMed ID: 17033614
[No Abstract] [Full Text] [Related]
4. Pharmacogenomics: questions and concerns.
Mahlknecht U; Voelter-Mahlknecht S
Curr Med Res Opin; 2005 Jul; 21(7):1041-7. PubMed ID: 16004671
[TBL] [Abstract][Full Text] [Related]
5. Family consent and the pursuit of better medicines through genetic research.
Renegar G; Rieser P; Manasco P
J Contin Educ Health Prof; 2001; 21(4):265-70. PubMed ID: 11803771
[TBL] [Abstract][Full Text] [Related]
6. [Ethics, politics, and rights in pharmacogenomics].
Bellver Capella V
Rev Derecho Genoma Hum; 2002; (17):31-55. PubMed ID: 12703107
[TBL] [Abstract][Full Text] [Related]
7. Ethics and policy perspectives on personalized medicine in the post-genomic era.
Landon MR
J Biolaw Bus; 2005; 8(3):28-36. PubMed ID: 16459425
[TBL] [Abstract][Full Text] [Related]
8. Ethical, legal and social implications of genetic testing.
EC Expert Group
Bull Med Ethics; 2004 Dec-2005 Jan; (204):9-11. PubMed ID: 15856582
[No Abstract] [Full Text] [Related]
9. Informed consent in the context of pharmacogenomic research: ethical considerations.
Howard HC; Joly Y; Avard D; Laplante N; Phillips M; Tardif JC
Pharmacogenomics J; 2011 Jun; 11(3):155-61. PubMed ID: 21445091
[TBL] [Abstract][Full Text] [Related]
10. Pharmacogenetics: the bioethical problem of DNA investment banking.
Corrigan OP; Williams-Jones B
Stud Hist Philos Biol Biomed Sci; 2006 Sep; 37(3):550-65. PubMed ID: 16980194
[TBL] [Abstract][Full Text] [Related]
11. Society and ethics - the genetics of disease.
Thomas SM
Curr Opin Genet Dev; 2004 Jun; 14(3):287-91. PubMed ID: 15172672
[TBL] [Abstract][Full Text] [Related]
12. Legal implications of pharmacogenomics regarding drug trials, drug labeling, and genetic testing for drug prescription: an international approach.
Mandry T
Food Drug Law J; 2004; 59(4):519-35. PubMed ID: 15875348
[TBL] [Abstract][Full Text] [Related]
13. Clinical and ethical considerations in pharmacogenetic testing: views of physicians in 3 "early adopting" departments of psychiatry.
Hoop JG; Lapid MI; Paulson RM; Roberts LW
J Clin Psychiatry; 2010 Jun; 71(6):745-53. PubMed ID: 20361898
[TBL] [Abstract][Full Text] [Related]
14. Context, ethics and pharmacogenetics.
Hedgecoe AM
Stud Hist Philos Biol Biomed Sci; 2006 Sep; 37(3):566-82. PubMed ID: 16980195
[TBL] [Abstract][Full Text] [Related]
15. Global gene mining and the pharmaceutical industry.
Knudsen LE
Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):679-83. PubMed ID: 15979678
[TBL] [Abstract][Full Text] [Related]
16. [Contributions of pharmacogenomics to enhance the efficiency of randomized clinical trials].
de Jesús Castillejos-López M; García-Sancho MC; Torres-Espíndola LM; Pérez-Padilla JR
Rev Invest Clin; 2006; 58(5):512-24. PubMed ID: 17408112
[TBL] [Abstract][Full Text] [Related]
17. Ethical and legal implications of pharmacogenomics.
Rothstein MA; Epps PG
Nat Rev Genet; 2001 Mar; 2(3):228-31. PubMed ID: 11256075
[TBL] [Abstract][Full Text] [Related]
18. Guthrie cards: legal and ethical issues.
Elkin K; Jones DG
N Z Bioeth J; 2000 Oct; 1(2):22-6. PubMed ID: 15586976
[No Abstract] [Full Text] [Related]
19. Selected legal and ethical issues relevant to pediatric genetics.
Nelson E; Haymond K; Sidarous M
Health Law J; 1998; 6 Spec No():83-113. PubMed ID: 14746062
[No Abstract] [Full Text] [Related]
20. Ethical, social and legal implications of genetic testing in liver disease.
van Leeuwen DJ; Bernat JL
Hepatology; 2006 Jun; 43(6):1195-201. PubMed ID: 16729331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
